Announces a policy guiding the authorization of alternative, non-opioid pain management treatments and treatment for opioid use disorder (OUD) for federal workers receiving workers' compensation. Aims to reduce barriers to non-opioid pain treatment, such as alternative pain medication, cognitive behavioral therapy (CBT), physical therapy, transcutaneous electrical nerve stimulation (TENS), and other treatment without medication, as well as in-patient pain management programs. Increases patient access to OUD treatments, including medication-assisted treatment (MAT), opioid treatment programs, in-patient, out-patient, and emergency services.

Announces a policy, effective September 23, 2019, whereby injured federal workers receiving workers' compensation that are newly prescribed opioids will be limited to an initial 7-day supply. Allows an injured worker to receive a maximum of four sequential 7-day supply prescriptions, an initial and three subsequent prescriptions, for a total of 28 days before prior authorization is required. For additional opioid prescriptions exceeding the initial 28-day period, the prescribing physician will need to submit a form certifying the medical necessity of continued opioid use for approval from the Office of Workers' Compensation Programs (OWCP).

Announces a four-point strategic plan to protect injured federal workers covered under the Federal Employee's Compensation Act from the risk of opioid misuse and addiction. Includes details on these policy initiatives and their progress, information on any new policies, as well as a discussion of opioid facts and risk factors for opioid misuse, addiction, and overdose, and links to additional resources.